Performance Evaluation of Cement–Rice Husk Ash Hybrid Binder Systems for Mine Reclamation Backfill: Influence of Binder Composition and Material Type on Mechanical and Physical Properties
International Journal of Innovative Science and Research Technology · 29.06.2026 · 1582
DOI: 10.38124/ijisrt/26jun1587 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 29.06.2026. Verfasst von Ogunyemi Olaoluwa Bidemi und 2 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
This study examined the mechanical and physical performance of marble-based backfill specimens prepared using two distinct binder strategies, cement-only formulations and hybrid cement–rice husk ash (RHA) systems, across four curing periods: 7, 14, 21 and 28 days.
Zitieren
APA
Bidemi, O. O., Stephen, A. O., & Emmanuel, O. O. (2026). Performance Evaluation of Cement–Rice Husk Ash Hybrid Binder Systems for Mine Reclamation Backfill: Influence of Binder Composition and Material Type on Mechanical and Physical Properties. International Journal of Innovative Science and Research Technology, 1582. https://doi.org/10.38124/ijisrt/26jun1587
Vancouver
Bidemi OO, Stephen AO, Emmanuel OO. Performance Evaluation of Cement–Rice Husk Ash Hybrid Binder Systems for Mine Reclamation Backfill: Influence of Binder Composition and Material Type on Mechanical and Physical Properties. International Journal of Innovative Science and Research Technology. 2026:1582. doi:10.38124/ijisrt/26jun1587
BibTeX
@article{Bidemi2026,
author = {Bidemi, Ogunyemi Olaoluwa and Stephen, Adesola Olubunmi and Emmanuel, Olamijulo Oluwapelumi},
title = {Performance Evaluation of Cement–Rice Husk Ash Hybrid Binder Systems for Mine Reclamation Backfill: Influence of Binder Composition and Material Type on Mechanical and Physical Properties},
journal = {International Journal of Innovative Science and Research Technology},
year = {2026},
pages = {1582},
doi = {10.38124/ijisrt/26jun1587}
}
EUVIMED